DXCM vs. RMD
DXCM (DexCom, Inc.) and RMD (ResMed Inc.) are both stocks. Both are in the Healthcare sector — DXCM in Diagnostics & Research, RMD in Medical Instruments & Supplies. Over the past 10 years, DXCM returned 13.56%/yr vs 13.30%/yr for RMD. At a 0.33 correlation, their price movements are largely independent.
Performance
DXCM vs. RMD - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, DXCM achieves a 4.07% return, which is significantly higher than RMD's -21.35% return. Both investments have delivered pretty close results over the past 10 years, with DXCM having a 13.56% annualized return and RMD not far behind at 13.30%.
DXCM
- 1D
- -4.69%
- 1M
- -4.20%
- YTD
- 4.07%
- 6M
- 2.43%
- 1Y
- -13.66%
- 3Y*
- -18.32%
- 5Y*
- -8.54%
- 10Y*
- 13.56%
RMD
- 1D
- -0.10%
- 1M
- -9.42%
- YTD
- -21.35%
- 6M
- -23.20%
- 1Y
- -24.99%
- 3Y*
- -3.40%
- 5Y*
- -4.15%
- 10Y*
- 13.30%
DXCM vs. RMD - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
DXCM DexCom, Inc. | 4.07% | -14.66% | -37.33% | 9.58% | -15.64% | 45.23% | 69.02% | 82.59% | 108.75% | -3.87% |
RMD ResMed Inc. | -21.35% | 6.26% | 34.18% | -16.55% | -19.47% | 23.41% | 38.33% | 37.85% | 36.38% | 39.06% |
Correlation
The correlation between DXCM and RMD is 0.31, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.31 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.34 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.41 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.40 |
Correlation (All Time) Calculated using the full available price history since Apr 14, 2005 | 0.33 |
Fundamentals
DXCM:
$2.31
RMD:
$13.78
DXCM:
29.85
RMD:
13.68
DXCM:
0.71
RMD:
0.42
DXCM:
5.76
RMD:
3.75
DXCM:
$4.82B
RMD:
$5.54B
DXCM:
$2.96B
RMD:
$3.42B
DXCM:
$1.37B
RMD:
$2.10B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
DXCM vs. RMD — Risk / Return Rank
DXCM
RMD
DXCM vs. RMD - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for DexCom, Inc. (DXCM) and ResMed Inc. (RMD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| DXCM | RMD | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.70 | ||
| Sortino ratioReturn per unit of downside risk | +1.16 | ||
| Omega ratioGain probability vs. loss probability | 0.97 | 0.84 | +0.14 |
| Calmar ratioReturn relative to maximum drawdown | -0.35 | -0.67 | +0.32 |
| Martin ratioReturn relative to average drawdown | -0.60 | -1.45 | +0.86 |
Loading charts...
Drawdowns
DXCM vs. RMD - Drawdown Comparison
The maximum DXCM drawdown since its inception was -94.61%, which is greater than RMD's maximum drawdown of -61.61%. Use the drawdown chart below to compare losses from any high point for DXCM and RMD.
Loading charts...
Drawdown Indicators
| DXCM | RMD | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -94.61% | -61.61% | -33.00% |
Max Drawdown (1Y)Largest decline over 1 year | -38.75% | -37.28% | -1.47% |
Max Drawdown (3Y)Largest decline over 3 years | -60.95% | -40.09% | -20.86% |
Max Drawdown (5Y)Largest decline over 5 years | -66.32% | -53.99% | -12.33% |
Max Drawdown (10Y)Largest decline over 10 years | -66.32% | -53.99% | -12.33% |
Current DrawdownCurrent decline from peak | -57.58% | -35.35% | -22.23% |
Average DrawdownAverage peak-to-trough decline | -36.04% | -16.01% | -20.03% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 22.94% | 17.21% | +5.73% |
Volatility
DXCM vs. RMD - Volatility Comparison
DexCom, Inc. (DXCM) has a higher volatility of 10.88% compared to ResMed Inc. (RMD) at 10.27%. This indicates that DXCM's price experiences larger fluctuations and is considered to be riskier than RMD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| DXCM | RMD | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.88% | 10.27% | +0.61% |
Volatility (6M)Calculated over the trailing 6-month period | 25.88% | 19.64% | +6.24% |
Volatility (1Y)Calculated over the trailing 1-year period | 41.18% | 24.42% | +16.76% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 47.07% | 31.00% | +16.07% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 48.45% | 31.55% | +16.90% |
Dividends
DXCM vs. RMD - Dividend Comparison
DXCM has not paid dividends to shareholders, while RMD's dividend yield for the trailing twelve months is around 1.27%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
DXCM DexCom, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
RMD ResMed Inc. | 1.27% | 0.94% | 0.88% | 1.07% | 0.83% | 0.62% | 0.73% | 0.98% | 1.26% | 1.61% | 2.03% | 2.16% |
Financials
DXCM vs. RMD - Financials Comparison
This section allows you to compare key financial metrics between DexCom, Inc. and ResMed Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
DXCM vs. RMD - Profitability Comparison
DXCM - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, DexCom, Inc. reported a gross profit of 750.30M and revenue of 1.19B. Therefore, the gross margin over that period was 63.0%.
RMD - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, ResMed Inc. reported a gross profit of 890.98M and revenue of 1.43B. Therefore, the gross margin over that period was 62.3%.
DXCM - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, DexCom, Inc. reported an operating income of 255.30M and revenue of 1.19B, resulting in an operating margin of 21.4%.
RMD - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, ResMed Inc. reported an operating income of 499.81M and revenue of 1.43B, resulting in an operating margin of 34.9%.
DXCM - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, DexCom, Inc. reported a net income of 199.50M and revenue of 1.19B, resulting in a net margin of 16.7%.
RMD - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, ResMed Inc. reported a net income of 398.73M and revenue of 1.43B, resulting in a net margin of 27.9%.
Frequently Asked Questions
DXCM and RMD have a correlation of 0.31, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
DXCM has higher volatility (10.88%) compared to RMD (10.27%). In terms of maximum drawdown, DXCM dropped -94.61% vs RMD's -61.61%.
DXCM currently has the higher Sharpe Ratio (-0.33 vs -1.03), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for DXCM and RMD
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer